Clinical Trials Sponsored by NEC Corporation
Total 11890 results
-
Masimo CorporationCompleted
-
Incyte CorporationCompletedMetastatic Melanoma | Unresectable Melanoma | Metastatic Urothelial Cancer | Metastatic Non-small Cell Lung Cancer | Locally Advanced Renal Cell Carcinoma | Locally Advanced Urothelial Cancer | Metastatic Clear-Cell Renal Cell CarcinomaFrance, Spain, United States, Italy, Austria, Romania, Poland, Hungary
-
Masimo CorporationCompleted
-
Masimo CorporationTerminatedSurgery | AnesthesiaUnited States
-
Antengene CorporationCompletedRelapse/Refractory Multiple MyelomaChina
-
Seikagaku CorporationCompletedLumbar Vertebra HerniaUnited States
-
Seikagaku CorporationCompletedLumbar Disc Disease | Intervertebral Disc DiseaseUnited States, Germany, Spain, Romania
-
Seikagaku CorporationCompleted
-
Koning CorporationTerminated
-
Incyte CorporationCompletedHead and Neck Cancer | Gastric Cancer | Lung Cancer | Metastatic Cancer | Mesothelioma | Bladder Cancer | Solid Tumors | Renal Cell Carcinoma (RCC) | Colorectal Cancer (CRC) | UC (Urothelial Cancer)Italy, Spain, United States, Netherlands
-
Incyte CorporationTerminatedAcute Graft-versus-host DiseaseUnited States, Spain, France, Italy, United Kingdom, Germany
-
Incyte CorporationApproved for marketingGraft-versus-host Disease (GVHD)
-
Yuhan CorporationCompletedAtopic Healthy Subjects | Adult Subjects With Mild Allergic DiseasesKorea, Republic of
-
Oxfo CorporationCompletedOxygen Deficiency | Oxygen TherapyColombia
-
Genelux CorporationCompletedOvarian Cancer | Fallopian Tube Cancer | Peritoneal CarcinomatosisUnited States
-
Caerus CorporationEnrolling by invitation
-
Allievex CorporationActive, not recruitingMucopolysaccharidosis Type IIIBUnited States, Germany, Spain, Argentina, Australia, Brazil, Colombia, Taiwan, Turkey
-
Masimo CorporationCompleted
-
Yuhan CorporationCompleted
-
Incyte CorporationCompletedA Placebo-Controlled Study of the Safety of INCB054707 in Participants With Hidradenitis SuppurativaHidradenitis SuppurativaCanada, Denmark, Germany
-
Incyte CorporationCompletedNon-segmental VitiligoUnited States, Canada, Italy, France, Germany, Spain, Poland, Bulgaria, Netherlands
-
Glaukos CorporationCompleted
-
Glaukos CorporationCompleted
-
Glaukos CorporationCompletedPrimary Open Angle Glaucoma (POAG)Armenia
-
Zxerex CorporationCompletedNeurologic Impairment by OpioidsUnited States
-
Topcon CorporationCompletedCorneal ThicknessJapan
-
Topcon CorporationCompleted
-
Masimo CorporationTerminatedAnemia | Carbon Monoxide PoisoningTurkey
-
Incyte CorporationCompletedB-cell LymphomaUnited States, Spain, Italy
-
Incyte CorporationCompletedHealthy VolunteersUnited Kingdom
-
Incyte CorporationCompletedMPN (Myeloproliferative Neoplasms)United States, Netherlands, Austria
-
Irrimax CorporationTerminatedSurgical Site InfectionUnited States
-
Glaukos CorporationCompletedPrimary Open-angle GlaucomaUnited States
-
Masimo CorporationCompleted
-
Masimo CorporationTerminated
-
Incyte CorporationCompletedMelanoma | Breast Cancer | Head and Neck Cancer | Pancreatic Cancer | Lung Cancer | Endometrial Cancer | Solid Tumors | Renal Cell Carcinoma (RCC) | Colorectal Cancer (CRC) | UC (Urothelial Cancer) | MMR-deficient TumorsUnited States
-
Candela CorporationCompleted
-
Erchonia CorporationCompletedDiabetic Peripheral NeuropathyUnited States, Ireland
-
Yuhan CorporationApproved for marketing
-
Yuhan CorporationCompletedHealthy Adult VolunteersKorea, Republic of
-
Cerus CorporationCompletedTransfusion Related Acute Lung InjuryUnited States
-
Incyte CorporationCompletedPsoriasisUnited States
-
Irrimax CorporationTerminatedAbscessUnited States
-
FA CorporationCompleted
-
Incyte CorporationTerminatedCOVID-19United States, Russian Federation
-
Yuhan CorporationTerminatedOtitis Media | OtorrheaKorea, Republic of
-
Yuhan CorporationTerminatedFunctional DyspepsiaKorea, Republic of